Research / CBT / Fundamental state Inspectable configuration
State dimensions Filing 0000950170-24-129210 General Corporate
Debt relative to revenue 5th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.debt_to_revenue
26.92% · OPTIONAL · VALID
Capex intensity 65th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.capex_revenue_ratio
6.03% · OPTIONAL · VALID
Operating cash generation 85th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
17.33% · OPTIONAL · VALID
Revenue growth 50th Own-history percentile · N=20
Evidence method Yoy · gp.fundamentals.revenue
1.60% · CORE · VALID
Inventory pressure 5th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
13.82% · OPTIONAL · VALID
Gross margin 80th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.gross_margin
24.04% · CORE · VALID
Operating margin 85th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.operating_margin
15.37% · CORE · VALID
R&D intensity 60th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
1.58% · OPTIONAL · VALID
SBC intensity 80th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
0.63% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 36 states Self-history eligible
Sep 30, 2021 9/9 normalized Level 3 Dec 31, 2021 9/9 normalized Level 3 Mar 31, 2022 9/9 normalized Level 3 Jun 30, 2022 9/9 normalized Level 3 Sep 30, 2022 9/9 normalized Level 3 Dec 31, 2022 9/9 normalized Level 3 Mar 31, 2023 9/9 normalized Level 3 Jun 30, 2023 9/9 normalized Level 3 Sep 30, 2023 9/9 normalized Level 3 Dec 31, 2023 9/9 normalized Level 3 Mar 31, 2024 9/9 normalized Level 3 Jun 30, 2024 9/9 normalized Level 3 Sep 30, 2024 9/9 normalized Level 3 Dec 31, 2024 9/9 normalized Level 3 Mar 31, 2025 9/9 normalized Level 3 Jun 30, 2025 9/9 normalized Level 3 Sep 30, 2025 9/9 normalized Level 3 Dec 31, 2025 9/9 normalized Level 3 Mar 31, 2026 9/9 normalized Level 3 Jun 30, 2026 9/9 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Decreased
Previous 112.20%
Current 26.92%
Delta -85.29% Capex Intensity Increased
Previous 5.12%
Current 6.03%
Delta 0.92% Cash Generation Decreased
Previous 20.37%
Current 17.33%
Delta -3.05% Growth Decreased
Previous 4.96%
Current 1.60%
Delta -3.36% Inventory Pressure Decreased
Previous 54.43%
Current 13.82%
Delta -40.61% Margin Decreased
Previous 25.20%
Current 24.04%
Delta -1.16% Profitability Decreased
Previous 16.93%
Current 15.37%
Delta -1.56% R And D Intensity Increased
Previous 1.57%
Current 1.58%
Delta 0.00% Sbc Intensity Increased
Previous 0.59%
Current 0.63%
Delta 0.04% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.